Sanofi Consumer Healthcare India Limited has officially announced the appointment of M/s. Price Waterhouse & Co Chartered Accountants LLP as its new Statutory Auditor. This decision, approved by the Board of Directors on May 25, 2026, follows the resignation of the previous auditor, M/s. Kalyaniwalla & Mistry LLP. The appointment is intended to fill the resulting casual vacancy and is subject to approval by the company’s shareholders at the ensuing Annual General Meeting (AGM).

Following the recommendation of the Audit Committee, the Board has appointed Price Waterhouse & Co Chartered Accountants LLP to serve until the conclusion of the upcoming AGM. Furthermore, the Board has approved their appointment for a five-year term, effective from the conclusion of the 2026 AGM until the Eighth AGM in 2031, pending shareholder approval. The new auditors are a prominent firm of Chartered Accountants established in 1991, with a nationwide presence and extensive experience auditing listed companies in India.

Sanofi Consumer Healthcare India Limited is a dedicated consumer healthcare entity that emerged as a standalone company following its demerger from Sanofi India Limited. The company focuses on “Fast Moving Consumer Healthcare” (FMCH) products, managing a portfolio of well-known brands such as Allegra, Combiflam, Avil, and DePURA. During 2025, the company prioritized building independent capabilities, including establishing a dedicated supply chain and increasing marketing investments to drive brand equity. The company operates extensively across India, leveraging a hybrid distribution model to reach retail consumers and healthcare professionals.

The company has demonstrated consistent growth, supported by both institutional and individual investors. As of the latest filings, promoter Sanofi maintains a 60.4% stake, with significant interest from mutual funds like Nippon India Growth Fund and Aditya Birla Sun Life Large Cap Fund. In terms of financial performance for the quarter ending in 2026, the company reported revenue of ₹234.80 Crore and a net profit of ₹67.80 Crore. This performance reflected a year-on-year revenue growth of 32.06% and a net profit growth of 35.6% compared to the same period in the previous year.